Andrew R. Boll
2012
In 2012, Andrew R. Boll earned a total compensation of $123.8K as Vice-President, Accounting and Public Reporting at Imprimis Pharmaceuticals.
Compensation breakdown
| Option Awards | $51,780 |
|---|---|
| Salary | $64,500 |
| Other | $7,524 |
| Total | $123,804 |
Boll received $64.5K in salary, accounting for 52% of the total pay in 2012.
Boll also received $51.8K in option awards and $7.5K in other compensation.
Rankings
In 2012, Andrew R. Boll's compensation ranked 11,235th out of 11,487 executives tracked by ExecPay. In other words, Boll earned more than 2.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,235 out of 11,487 | 2nd |
Division Manufacturing | 4,174 out of 4,253 | 2nd |
Major group Chemicals And Allied Products | 1,176 out of 1,203 | 2nd |
Industry group Drugs | 903 out of 925 | 2nd |
Industry Pharmaceutical Preparations | 681 out of 700 | 3rd |
Source: SEC filing on July 17, 2013.
Boll's colleagues
We found three more compensation records of executives who worked with Andrew R. Boll at Imprimis Pharmaceuticals in 2012.
News
Imprimis Pharmaceuticals CEO Mark Baum's 2022 pay falls 84% to $1.2M
April 28, 2023
Imprimis Pharmaceuticals CEO Mark Baum's 2021 pay jumps 195% to $7.3M
April 26, 2022
Imprimis Pharmaceuticals CEO Mark Baum's 2020 pay jumps 80% to $2.5M
April 23, 2021
Imprimis Pharmaceuticals CEO Mark Baum's 2019 pay jumps 30% to $1.4M
April 24, 2020
Imprimis Pharmaceuticals CEO Mark Baum's 2018 pay rises 16% to $1.1M
April 25, 2019